Discontinuation report LODALIS
| Report ID | 212799 |
| Drug Identification Number | 02432463 |
| Brand name | LODALIS |
| Common or Proper name | LODALIS |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | COLESEVELAM HYDROCHLORIDE |
| Strength(s) | 3.75G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | sachet |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-12-01 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-02-20 | English | Compare |
| v2 | 2023-12-08 | French | Compare |
| v1 | 2023-12-08 | English | Compare |
Showing 1 to 3 of 3